NGSサンプル前処理市場：製品（試薬・消耗品、ワークステーション）、ワークフロー（ライブラリー前処理、ターゲットエンリッチメント）、サンプルタイプ（DNA）、アプリケーション（診断、創薬）、方法（マイクロ流体、自動化）、エンドユーザー＆地域別 - 2028年までの世界予測

NGS Sample Preparation Market by Product (Reagents & Consumables, Workstations), Workflow (Library Prep, Target Enrichment), Sample Type (DNA), Application (Diagnostics, Drug Discovery), Method (Microfluidic, Automated), End User & Region - Global Forecast to 2028

NGSサンプル調製市場は、予測期間中に13.4%のCAGRで、2022年の19億米ドルから2028年には40億米ドルに達すると予測されます。NGSサンプル調製市場の成長を促進する主な要因は、NGSプラットフォームにおける絶え間... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2023年3月6日	US$4,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	289	346	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

NGSサンプル調製市場は、予測期間中に13.4%のCAGRで、2022年の19億米ドルから2028年には40億米ドルに達すると予測されます。NGSサンプル調製市場の成長を促進する主な要因は、NGSプラットフォームにおける絶え間ない技術革新と、高度なNGSシステムを低コストで利用できるようになったことです。しかし、代替技術の存在により、市場の成長はある程度抑制されると予想されます。
NGSサンプル前処理市場は、製品・サービス、ワークフロー、サンプルタイプ、メソッド、アプリケーション、エンドユーザー、地域に基づいてセグメント化されています。
"アプリケーション別では、疾患診断がNGSサンプル調製市場で最大のシェアを占めている"
アプリケーションに基づき、NGSサンプル調製市場は、疾患診断、創薬、農業・動物研究、その他に分類される。NGSベースの検査に対する有利な償還シナリオや、がんやNIPT向けのNGSベースの製品＆サービスの開発に対する主要プレイヤーの注力度の高まりにより、2022年には疾病診断分野が市場を支配しました。
"エンドユーザー別では、学術機関＆研究センターがNGSサンプル調製市場で最大のシェアを占める"
エンドユーザーに基づき、NGSサンプル調製市場は、病院＆クリニック、学術機関＆研究センター、製薬＆バイオテクノロジー企業、およびその他のエンドユーザーに区分されます。2022年には、学術機関＆研究センターセグメントがNGSサンプル調製市場でより大きなシェアを占めています。この市場セグメントの成長は、地域ごとにゲノミクス研究開発のための財政支援が受けられること、研究者向けに費用対効果の高いNGS製品＆サービスが開発されていることに起因していると考えられます。

"北米：NGSサンプル調製市場で最大のシェア"
NGSサンプル前処理市場は、北米が最大のシェアを占めています。NGS技術の導入に向けた政府や民間団体による好意的な取り組み、NGSサンプル調製製品の進歩、対象疾患の有病率の増加、NGSベースの研究・臨床アプリケーションの増加、がんに関する研究の増加、NGSサービスに対する認知度の向上、イルミナ（米）、サーモフィッシャーサイエンティフィック（米）、アジレントテクノロジー（米）などの主要NGSサービスプロバイダーの存在が、北米におけるNGSサンプル調製市場の成長を促進しています。
"アジア太平洋地域NGSサンプル調製市場で最も成長率の高い地域"
アジア太平洋地域のNGSサンプル調製市場は、予測期間中に最も高いCAGRで成長すると予測されていますが、これは主にNGSアプリケーションの範囲を広げる手段として研究開発活動に大きく注力していること、NGS製品およびサービスのコスト低下により診断へのNGS導入が増加していること、NGSデータ解析の技術開発によるものです。また、国内外の多くの市場関係者がアジア太平洋地域のNGS市場におけるプレゼンスの強化に注力しており、国内関係者はパートナーシップ、コラボレーション、合意、拡張を通じて国際的なリーチを拡大しています。
本レポートのために実施した一次インタビューは、以下のように分類されます：

- 回答者別サプライサイド60％、デマンドサイド40
- 職位別エグゼクティブ40％、リサーチサイエンティスト30％、マネージャー30
- 国別北米22％、欧州42％、アジア太平洋11％、中南米20％、MEA5％。

著名なプレーヤー
- イルミナ社（米国）
- サーモフィッシャーサイエンティフィック社(米国)
- パーキンエルマー社(米国)
- F.ホフマン・ラ・ロシュ社（スイス(スイス)
- アジレント・テクノロジー株式会社（米国）
- ダナハー（米国）
- ベクトン・ディッキンソン・アンド・カンパニー（米国）
- メルクKGAA（ドイツ）
- QIAGEN社（ドイツ）
- バイオ・ラッド・ラボラトリーズ・インク（米国）
- プロメガ・コーポレーション（米国）
- ユーロフィンズサイエンティフィック（ルクセンブルク）
- BGI（中国）
- 10x Genomics（米国）
- シスメックスコーポレーション（米国）
- プソマジェン（米国）
- ザイモ・リサーチ・コーポレーション（米国）
- タカラバイオ株式会社（日本）
- Novogene Co.(中国)
- ニューイングランド・バイオラボス（米国）
- テカントレーディングAG（米国）
- オックスフォード・ナノポア・テクノロジーズ PLC（英国）
- パクビオ（米国）
- メドゲノム（米国）
- スウィフト・バイオサイエンス社（米国）
調査対象です：
本レポートは、NGSサンプル調製市場の詳細な情報を提供します。製品＆サービス、ワークフロー、サンプルタイプ、メソッド、アプリケーション、エンドユーザー、地域などの異なるセグメントにおける市場規模および今後の成長可能性を推定することを目的としています。また、主要な市場プレイヤーの会社概要、最近の開発状況、主要な市場戦略とともに、詳細な競合分析も行っています。
レポート購入の主なメリット
本レポートは、NGSサンプル調製市場全体とそのセグメントの収益数の最も近い近似値を提供することで、市場リーダー/新規参入者を支援します。また、利害関係者が競争環境をよりよく理解し、より多くの洞察を得ることで、自社のビジネスをよりよく位置づけ、適切な市場参入戦略を立てるのに役立ちます。本レポートは、関係者が市場の脈を理解し、主要な市場促進要因、阻害要因、動向、機会、および課題に関する情報を提供することを可能にします。

ページTOPに戻る

1 INTRODUCTION 40
1.1 STUDY OBJECTIVES 40
1.2 MARKET DEFINITION 40
1.2.1 INCLUSIONS AND EXCLUSIONS 41
1.3 STUDY SCOPE 42
1.4 YEARS CONSIDERED 43
1.5 CURRENCY CONSIDERED 43
1.6 RESEARCH LIMITATIONS 43
1.7 STAKEHOLDERS 43
2 RESEARCH METHODOLOGY 44
2.1 RESEARCH DATA 44
FIGURE 1 RESEARCH DESIGN 44
2.1.1 SECONDARY DATA 44
2.1.2 PRIMARY DATA 45
FIGURE 2 BREAKDOWN OF PRIMARIES 46
2.2 MARKET ESTIMATION METHODOLOGY 46
FIGURE 3 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS), 2021 47
FIGURE 4 NGS SAMPLE PREPARATION MARKET SIZE (USD MILLION) 48
FIGURE 5 NGS SAMPLE PREPARATION MARKET: FINAL CAGR PROJECTIONS (2023−2028) 48
FIGURE 6 NGS SAMPLE PREPARATION MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 49
2.3 MARKET DATA ESTIMATION AND TRIANGULATION 50
FIGURE 7 DATA TRIANGULATION METHODOLOGY 50
2.4 INDUSTRY INSIGHTS 51
2.5 STUDY ASSUMPTIONS 51
2.6 GLOBAL RECESSION IMPACT: NGS SAMPLE PREPARATION MARKET 51
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH) 52
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 52
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION) 52
3 EXECUTIVE SUMMARY 54
FIGURE 8 NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2022 VS. 2028 (USD MILLION) 54
FIGURE 9 NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2022 VS. 2028 (USD MILLION) 55
FIGURE 10 NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2022 VS. 2028 (USD MILLION) 55
FIGURE 11 NGS SAMPLE PREPARATION MARKET, BY METHOD, 2022 VS. 2028 (USD MILLION) 56
FIGURE 12 NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2022 VS. 2028 (USD MILLION) 57
FIGURE 13 NGS SAMPLE PREPARATION MARKET, BY END USER, 2022 VS. 2028 (USD MILLION) 57
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF NGS SAMPLE PREPARATION MARKET 58
4 PREMIUM INSIGHTS 59
4.1 NGS SAMPLE PREPARATION MARKET OVERVIEW 59
FIGURE 15 ADVANCEMENTS IN NGS PLATFORMS TO DRIVE GROWTH 59
4.2 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE AND COUNTRY (2022) 60
FIGURE 16 REAGENTS & CONSUMABLES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 60
4.3 NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2022 VS. 2028 60
FIGURE 17 DISEASE DIAGNOSTICS SEGMENT TO DOMINATE MARKET IN 2028 60
4.4 NGS SAMPLE PREPARATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 61
FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 61
5 MARKET OVERVIEW 62
5.1 INTRODUCTION 62
5.2 MARKET DYNAMICS 62
FIGURE 19 NGS SAMPLE PREPARATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 62
TABLE 4 NGS SAMPLE PREPARATION MARKET: IMPACT ANALYSIS 63
5.2.1 DRIVERS 63
5.2.1.1 Constant innovations in NGS platforms 63
5.2.1.2 Increased availability of advanced NGS systems at low costs 64
FIGURE 20 COST PER HUMAN GENOME, 2001–2021 64
5.2.1.3 Use of NGS as substitute for PCR 65
5.2.1.4 Greater efficiency of genotyping and preparation protocols 65
5.2.2 RESTRAINTS 65
5.2.2.1 Presence of alternative technologies 65
5.2.2.2 Limited expertise and sequencing capabilities of individual laboratories 65
5.2.3 OPPORTUNITIES 66
5.2.3.1 Increasing collaborations and partnerships among key players 66
5.2.4 CHALLENGES 66
5.2.4.1 Ethical and privacy issues in health data 66
5.3 TECHNOLOGY ANALYSIS 67
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 67
FIGURE 21 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 67
5.5 SUPPLY AND VALUE CHAIN ANALYSIS 68
5.5.1 SUPPLY CHAIN ANALYSIS OF NGS SAMPLE PREPARATION MARKET 68
FIGURE 22 NGS SAMPLE PREPARATION MARKET: SUPPLY CHAIN ANALYSIS 69
5.5.2 VALUE CHAIN ANALYSIS OF NGS SAMPLE PREPARATION MARKET 69
FIGURE 23 NGS SAMPLE PREPARATION MARKET: VALUE CHAIN ANALYSIS 69
5.6 ECOSYSTEM ANALYSIS 70
FIGURE 24 NGS SAMPLE PREPARATION MARKET: ECOSYSTEM ANALYSIS 70
5.7 PORTER’S FIVE FORCES ANALYSIS 71
TABLE 5 NGS SAMPLE PREPARATION MARKET: PORTER’S FIVE FORCES ANALYSIS 71
5.7.1 THREAT OF NEW ENTRANTS 71
5.7.2 THREAT OF SUBSTITUTES 71
5.7.3 BARGAINING POWER OF BUYERS 71
5.7.4 BARGAINING POWER OF SUPPLIERS 72
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 72
5.8 REGULATORY ANALYSIS 72
5.8.1 FDA APPROVALS 72
5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72
TABLE 6 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72
TABLE 7 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
TABLE 8 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
TABLE 9 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75
5.9 PRICING ANALYSIS 75
TABLE 10 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT 75
5.9.1 AVERAGE SELLING PRICE TREND ANALYSIS 76
5.10 PATENT ANALYSIS 76
FIGURE 25 PATENT FILING TRENDS FOR TOP 5 IPC MAIN CLASSES, 2018−2020 76
5.11 KEY CONFERENCES AND EVENTS IN 2023 77
5.11.1 CONFERENCES ON NGS SAMPLE PREPARATION IN 2023 77
TABLE 11 CONFERENCES ON NGS SAMPLE PREPARATION (2023) 77
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 77
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 77
FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS IN NGS SAMPLE PREPARATION MARKET 77
5.12.2 BUYING CRITERIA FOR NGS SAMPLE PREPARATION MARKET 78
FIGURE 27 KEY BUYING CRITERIA FOR END USERS 78

6 NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE 79
6.1 INTRODUCTION 80
TABLE 12 NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 80
6.2 WORKSTATIONS/INSTRUMENTS 80
6.2.1 INCREASING DEMAND FOR AUTOMATION OF NGS TO PROPEL MARKET 80
TABLE 13 NGS SAMPLE PREPARATION MARKET FOR WORKSTATIONS/INSTRUMENTS, BY REGION, 2021–2028 (USD MILLION) 81
TABLE 14 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR WORKSTATIONS/INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 81
TABLE 15 EUROPE: NGS SAMPLE PREPARATION MARKET FOR WORKSTATIONS/INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 82
TABLE 16 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR WORKSTATIONS/INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 82
TABLE 17 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR WORKSTATIONS/INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 83
6.3 REAGENTS & CONSUMABLES 83
6.3.1 GROWING USE OF CONSUMABLES FOR NGS SAMPLE PREPARATION TO DRIVE MARKET 83
TABLE 18 NGS SAMPLE PREPARATION MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2021–2028 (USD MILLION) 84
TABLE 19 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 20 EUROPE: NGS SAMPLE PREPARATION MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 21 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 85
TABLE 22 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 85
6.4 SERVICES 85
6.4.1 INCREASING INSTALLATION OF NGS PLATFORMS TO SUPPORT MARKET 85
TABLE 23 NGS SAMPLE PREPARATION MARKET FOR SERVICES, BY REGION, 2021–2028 (USD MILLION) 86
TABLE 24 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 25 EUROPE: NGS SAMPLE PREPARATION MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 87
TABLE 26 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 87
TABLE 27 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 88

7 NGS SAMPLE PREPARATION MARKET, BY WORKFLOW 89
7.1 INTRODUCTION 90
TABLE 28 NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 90
7.2 DNA FRAGMENTATION & LIBRARY PREPARATION 90
7.2.1 AVAILABILITY OF PRODUCTS FROM VARIOUS PLAYERS TO DRIVE MARKET 90
TABLE 29 NGS SAMPLE PREPARATION MARKET FOR DNA FRAGMENTATION & LIBRARY PREPARATION, BY REGION, 2021–2028 (USD MILLION) 91
TABLE 30 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR DNA FRAGMENTATION & LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 91
TABLE 31 EUROPE: NGS SAMPLE PREPARATION MARKET FOR DNA FRAGMENTATION & LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 92
TABLE 32 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR DNA FRAGMENTATION & LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 92
TABLE 33 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR DNA FRAGMENTATION & LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 93
7.3 TARGET ENRICHMENT 93
7.3.1 LAUNCH OF ADVANCED TARGET ENRICHMENT SOLUTIONS AND TECHNOLOGIES TO DRIVE MARKET 93
TABLE 34 NGS SAMPLE PREPARATION MARKET FOR TARGET ENRICHMENT, BY REGION, 2021–2028 (USD MILLION) 94
TABLE 35 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR TARGET ENRICHMENT, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 36 EUROPE: NGS SAMPLE PREPARATION MARKET FOR TARGET ENRICHMENT, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 37 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR TARGET ENRICHMENT, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 38 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR TARGET ENRICHMENT, BY COUNTRY, 2021–2028 (USD MILLION) 95
7.4 QUALITY CONTROL 95
7.4.1 RISING NUMBER OF RESEARCH ACTIVITIES REQUIRING QUALITY-ASSURED SAMPLES TO PROPEL MARKET 95
TABLE 39 NGS SAMPLE PREPARATION MARKET FOR QUALITY CONTROL, BY REGION, 2021–2028 (USD MILLION) 96
TABLE 40 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR QUALITY CONTROL, BY COUNTRY, 2021–2028 (USD MILLION) 96
TABLE 41 EUROPE: NGS SAMPLE PREPARATION MARKET FOR QUALITY CONTROL, BY COUNTRY, 2021–2028 (USD MILLION) 96
TABLE 42 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR QUALITY CONTROL, BY COUNTRY, 2021–2028 (USD MILLION) 97
TABLE 43 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR QUALITY CONTROL, BY COUNTRY, 2021–2028 (USD MILLION) 97

8 NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE 98
8.1 INTRODUCTION 99
TABLE 44 NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 99
8.2 DNA 99
8.2.1 RISING NUMBER OF CANCER CASES AND GROWING R&D INVESTMENTS FOR STUDYING DNA SAMPLES TO DRIVE MARKET 99
TABLE 45 NGS SAMPLE PREPARATION MARKET FOR DNA, BY REGION, 2021–2028 (USD MILLION) 99
TABLE 46 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR DNA, BY COUNTRY, 2021–2028 (USD MILLION) 100
TABLE 47 EUROPE: NGS SAMPLE PREPARATION MARKET FOR DNA, BY COUNTRY, 2021–2028 (USD MILLION) 100
TABLE 48 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR DNA, BY COUNTRY, 2021–2028 (USD MILLION) 100
TABLE 49 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR DNA, BY COUNTRY, 2021–2028 (USD MILLION) 101
8.3 RNA 101
8.3.1 DECREASED COSTS OF GENOME SEQUENCING TO AUGMENT MARKET 101
TABLE 50 NGS SAMPLE PREPARATION MARKET FOR RNA, BY REGION, 2021–2028 (USD MILLION) 101
TABLE 51 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR RNA, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 52 EUROPE: NGS SAMPLE PREPARATION MARKET FOR RNA, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 53 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR RNA, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 54 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR RNA, BY COUNTRY, 2021–2028 (USD MILLION) 103
9 NGS SAMPLE PREPARATION MARKET, BY APPLICATION 104
9.1 INTRODUCTION 105
TABLE 55 NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 105
9.2 DISEASE DIAGNOSTICS 105
TABLE 56 NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 106
TABLE 57 NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY REGION, 2021–2028 (USD MILLION) 106
TABLE 58 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 59 EUROPE: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 60 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 61 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 108
9.2.1 CANCER DIAGNOSTICS 108
9.2.1.1 Increase in cancer patients globally and launch of NGS-based cancer panels to drive market 108
TABLE 62 CANCER DIAGNOSTICS MARKET, BY REGION, 2021–2028 (USD MILLION) 109
TABLE 63 NORTH AMERICA: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 64 EUROPE: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 65 ASIA PACIFIC: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
TABLE 66 LATIN AMERICA: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
9.2.2 REPRODUCTIVE HEALTH DIAGNOSTICS 110
9.2.2.1 Increasing awareness about benefits of NIPT and decreasing costs of sequencing to propel market 110
TABLE 67 REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY REGION, 2021–2028 (USD MILLION) 111
TABLE 68 NORTH AMERICA: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 69 EUROPE: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 70 ASIA PACIFIC: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 71 LATIN AMERICA: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 113
9.2.3 INFECTIOUS DISEASE DIAGNOSTICS 113
9.2.3.1 Growing burden of healthcare-associated infections to aid market 113
TABLE 72 INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2021–2028 (USD MILLION) 114
TABLE 73 NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 74 EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 75 ASIA PACIFIC: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 76 LATIN AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 115
9.2.4 OTHER DISEASE DIAGNOSTIC APPLICATIONS 115
TABLE 77 OTHER DISEASE DIAGNOSTIC APPLICATIONS MARKET, BY REGION, 2021–2028 (USD MILLION) 116
TABLE 78 NORTH AMERICA: OTHER DISEASE DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 116
TABLE 79 EUROPE: OTHER DISEASE DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 116
TABLE 80 ASIA PACIFIC: OTHER DISEASE DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 81 LATIN AMERICA: OTHER DISEASE DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 117
9.3 DRUG DISCOVERY 117
9.3.1 INCREASING USE OF NGS DURING CLINICAL TRIALS TO AUGMENT MARKET 117
TABLE 82 NGS SAMPLE PREPARATION MARKET FOR DRUG DISCOVERY, BY REGION, 2021–2028 (USD MILLION) 118
TABLE 83 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 84 EUROPE: NGS SAMPLE PREPARATION MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION) 119
TABLE 85 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION) 119
TABLE 86 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION) 120
9.4 AGRICULTURAL & ANIMAL RESEARCH 120
9.4.1 INCREASED FUNDING AND SUPPORT FOR ANIMAL AND PLANT GENOMICS RESEARCH TO FUEL ADOPTION 120
TABLE 87 NGS SAMPLE PREPARATION MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY REGION, 2021–2028 (USD MILLION) 121
TABLE 88 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 89 EUROPE: NGS SAMPLE PREPARATION MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 90 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 91 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 122
9.5 OTHER APPLICATIONS 122
TABLE 92 NGS SAMPLE PREPARATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 123
TABLE 93 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 94 EUROPE: NGS SAMPLE PREPARATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 95 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 96 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 124
10 NGS SAMPLE PREPARATION MARKET, BY METHOD 125
10.1 INTRODUCTION 126
TABLE 97 NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 126
10.2 MANUAL SAMPLE PREPARATION 126
10.2.1 ERRORS ASSOCIATED WITH NGS MANUAL SAMPLE PREPARATION TO HINDER MARKET 126
TABLE 98 NGS SAMPLE PREPARATION MARKET FOR MANUAL SAMPLE PREPARATION, BY REGION, 2021–2028 (USD MILLION) 127
TABLE 99 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR MANUAL SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 100 EUROPE: NGS SAMPLE PREPARATION MARKET FOR MANUAL SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 101 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR MANUAL SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 128
TABLE 102 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR MANUAL SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 128
10.3 MICROFLUIDIC SAMPLE PREPARATION 128
10.3.1 GROWING APPLICATIONS OF MICROFLUIDIC SAMPLE PREPARATION TO CREATE OPPORTUNITIES 128
TABLE 103 NGS SAMPLE PREPARATION MARKET FOR MICROFLUIDIC SAMPLE PREPARATION, BY REGION, 2021–2028 (USD MILLION) 129
TABLE 104 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR MICROFLUIDIC SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 105 EUROPE: NGS SAMPLE PREPARATION MARKET FOR MICROFLUIDIC SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 106 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR MICROFLUIDIC SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 107 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR MICROFLUIDIC SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 131
10.4 AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION 131
10.4.1 HIGH PERFORMANCE AND ACCURACY OF AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION TO BOOST GROWTH 131
TABLE 108 NGS SAMPLE PREPARATION MARKET FOR AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION, BY REGION, 2021–2028 (USD MILLION) 131
TABLE 109 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 110 EUROPE: NGS SAMPLE PREPARATION MARKET FOR AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 111 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 112 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 133
11 NGS SAMPLE PREPARATION MARKET, BY END USER 134
11.1 INTRODUCTION 135
TABLE 113 NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION) 135
11.2 HOSPITALS & CLINICS 135
11.2.1 ADVANTAGES OF NGS TECHNOLOGY FOR DISEASE DIAGNOSIS OVER CONVENTIONAL METHOD TO FUEL ADOPTION 135
TABLE 114 NGS SAMPLE PREPARATION MARKET FOR HOSPITALS & CLINICS, BY REGION, 2021–2028 (USD MILLION) 136
TABLE 115 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION) 136
TABLE 116 EUROPE: NGS SAMPLE PREPARATION MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 117 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 118 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION) 138
11.3 ACADEMIC INSTITUTES & RESEARCH CENTERS 138
11.3.1 AVAILABILITY OF FINANCIAL SUPPORT FOR GENOMICS RESEARCH TO SUPPORT SEGMENT 138
TABLE 119 NGS SAMPLE PREPARATION MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY REGION, 2021–2028 (USD MILLION) 139
TABLE 120 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 121 EUROPE: NGS SAMPLE PREPARATION MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 140
TABLE 122 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 140
TABLE 123 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 141
11.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 141
11.4.1 GROWING COLLABORATIONS BETWEEN NGS MARKET PLAYERS AND PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DRIVE GROWTH 141
TABLE 124 NGS SAMPLE PREPARATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 142
TABLE 125 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 126 EUROPE: NGS SAMPLE PREPARATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 143
TABLE 127 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 143
TABLE 128 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 144
11.5 OTHER END USERS 144
TABLE 129 NGS SAMPLE PREPARATION MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 144
TABLE 130 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 145
TABLE 131 EUROPE: NGS SAMPLE PREPARATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 145
TABLE 132 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 133 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 146

12 NGS SAMPLE PREPARATION MARKET, BY REGION 147
12.1 INTRODUCTION 148
FIGURE 28 NGS SAMPLE PREPARATION MARKET, BY REGION, 2021 VS. 2028 (USD MILLION) 148
TABLE 134 NGS SAMPLE PREPARATION MARKET, BY REGION, 2021–2028 (USD MILLION) 149
12.2 NORTH AMERICA 149
FIGURE 29 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET SNAPSHOT 150
TABLE 135 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 150
TABLE 136 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 151
TABLE 137 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 151
TABLE 138 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 151
TABLE 139 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 152
TABLE 140 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 152
TABLE 141 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 153
TABLE 142 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 153
12.2.1 US 153
12.2.1.1 Favorable regulatory and reimbursement scenarios to drive market 153
TABLE 143 US: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 154
TABLE 144 US: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 154
TABLE 145 US: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 155
TABLE 146 US: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 155
TABLE 147 US: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 155
TABLE 148 US: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 156
TABLE 149 US: NGS SAMPLE PREPARATION MARKET BY END USER, 2021–2028 (USD MILLION) 156
12.2.2 CANADA 156
12.2.2.1 Favorable government funding to boost genomics research 156
TABLE 150 CANADA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 157
TABLE 151 CANADA: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 157
TABLE 152 CANADA: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 158
TABLE 153 CANADA: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 158
TABLE 154 CANADA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 158
TABLE 155 CANADA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 159
TABLE 156 CANADA: NGS SAMPLE PREPARATION MARKET, FOR END USER, 2021–2028 (USD MILLION) 159
12.2.3 NORTH AMERICA: IMPACT OF RECESSION 159
12.3 EUROPE 160
TABLE 157 EUROPE: NGS SAMPLE PREPARATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 160
TABLE 158 EUROPE: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 161
TABLE 159 EUROPE: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 161
TABLE 160 EUROPE: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 161
TABLE 161 EUROPE: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 162
TABLE 162 EUROPE: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 162
TABLE 163 EUROPE: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 163
TABLE 164 EUROPE: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION) 163
12.3.1 GERMANY 163
12.3.1.1 Strong R&D base and presence of several NGS players to support market 163
TABLE 165 GERMANY: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 164
TABLE 166 GERMANY: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 165
TABLE 167 GERMANY: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 165
TABLE 168 GERMANY: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 166
TABLE 169 GERMANY: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 166
TABLE 170 GERMANY: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 171 GERMANY: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION) 167
12.3.2 UK 167
12.3.2.1 Use of NGS-based tests for disease diagnosis to augment market 167
TABLE 172 UK: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 168
TABLE 173 UK: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 169
TABLE 174 UK NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 169
TABLE 175 UK NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 169
TABLE 176 UK: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 170
TABLE 177 UK: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 178 UK: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION) 171
12.3.3 FRANCE 171
12.3.3.1 Growing government support for genomics research to propel market 171
TABLE 179 FRANCE: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 172
TABLE 180 FRANCE: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 172
TABLE 181 FRANCE: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 173
TABLE 182 FRANCE: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 173
TABLE 183 FRANCE: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 173
TABLE 184 FRANCE: NGS SAMPLE PREPARATION MARKET BY DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 185 FRANCE: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION) 174
12.3.4 REST OF EUROPE 174
TABLE 186 REST OF EUROPE NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 175
TABLE 187 REST OF EUROPE: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 175
TABLE 188 REST OF EUROPE: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 176
TABLE 189 REST OF EUROPE: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 176
TABLE 190 REST OF EUROPE: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 177
TABLE 191 REST OF EUROPE: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 192 REST OF EUROPE: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION) 178
12.3.5 EUROPE: IMPACT OF RECESSION 178

ページTOPに戻る

Table of Contents

Summary

The NGS sample preparation market is projected to reach USD 4.0 billion by 2028 from USD 1.9 billion in 2022, at a CAGR of 13.4% during the forecast period. The key factors driving the growth of the NGS sample preparation market are constant innovations in NGS platforms, and increased availability of advanced NGS systems at low costs. However, the presence of alternative technologies is expected to restrain market growth to a certain extent.
The NGS sample preparation market has been segmented based on products & services, workflow, sample type, method, application, end user, and region.
“By application, the disease diagnostics accounted for the largest share of the NGS sample preparation market”
Based on application, the NGS sample preparation market is categorized into disease diagnostics, drug discovery, agricultural & animal research, and others. The disease diagnostics segment dominated the market in 2022, owing to favorable reimbursement scenario for NGS-based tests and increasing focus of key players on developing NGS-based products & services for cancer and NIPT are the key factors driving the growth of the segment.
“By end user, the academic institutes & research centers accounted for the largest share in the NGS Sample Preparation market”
Based on end user, the NGS sample preparation market is segmented into hospitals & clinics, academic institutes & research centers, pharmaceutical & biotechnology companies, and other end users. In 2022, the academic institutes & research centers segment accounted for a larger share of the NGS sample preparation market. Growth in this market segment can be attributed to availability of financial support for genomics R&D across regions, and the development of cost-effective NGS products & services for researchers.

“North America: the largest share of the NGS sample preparation market”
North America accounted for the largest share of the NGS sample preparation market. Favorable initiatives by government and private bodies for the adoption of NGS technologies, advancements in NGS sample preparation products, the growing prevalence of target diseases, an increasing number of NGS-based research & clinical applications, growing research on cancer, the rising awareness of NGS services, and the presence of leading NGS service providers, such as Illumina (US), Thermo Fisher Scientific (US), and Agilent Technologies (US), are driving the growth of the NGS sample preparation market in North America.
“Asia Pacific: The fastest-growing region in the NGS sample preparation market.”
The Asia Pacific NGS sample preparation market is projected to grow at the highest CAGR during the forecast period, mainly due to significant focus on R&D activities as a means of broadening the scope of NGS applications, the increasing adoption of NGS for diagnostics due to the decreasing cost of NGS products and services, and technological development in NGS data analysis. In addition, a number of domestic and international market players focus on strengthening their presence in the Asia Pacific NGS market, while domestic players expand their international reach through partnerships, collaborations, agreements, and expansions.
The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 60% and Demand Side 40%
• By Designation: Executives - 40%, Research Scientists- 30%, and Managers - 30%
• By Country: North America- 22%, Europe- 42%, Asia Pacific- 11%, Latin America- 20%, and MEA- 5%

Prominent Players
• Illumina, Inc. (US)
• Thermo Fisher Scientific Inc. (US)
• PerkinElmer Inc. (US)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Agilent Technologies, Inc. (US)
• Danaher (US)
• Becton, Dickinson and Company (US)
• Merck KGAA (Germany)
• QIAGEN (Germany)
• Bio-Rad Laboratories, Inc. (US)
• Promega Corporation (US)
• Eurofins Scientific (Luxembourg)
• BGI (China)
• 10x Genomics (US)
• Sysmex Corporation (US)
• Psomagen (US)
• Zymo Research Corporation (US)
• Takara Bio Inc. (Japan)
• Novogene Co., Ltd. (China)
• New England Biolabs (US)
• Tecan Trading AG (US)
• Oxford Nanopore Technologies PLC (UK)
• PacBio (US)
• Medgenome (US)
• Swift Biosciences Inc. (US)
Research Coverage:
This report provides a detailed picture of the NGS sample preparation market. It aims at estimating the size and future growth potential of the market across different segments, such as the product & services, workflow, sample type, method, applications, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall NGS sample preparation market and its segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（バイオ薬物）の最新刊レポート

MarketsandMarkets社のBiotechnology分野での最新刊レポート

本レポートと同じKEY WORD（sample）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（バイオ薬物）の最新刊レポート

MarketsandMarkets社のBiotechnology分野での最新刊レポート

本レポートと同じKEY WORD（sample）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?